Significant increase in volume has been observed in Sun Pharma Advanced Research Company Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

This event is creating a negative ripple across Indian equity markets. The primary transmission channels are institutional flows, market sentiment, and sector rotation patterns. The impact is expected to be most pronounced in the near term with gradual normalization over 2-4 weeks.